Outcome markers in COPD patients with COVID-19

Brasil Notícia Notícia

Outcome markers in COPD patients with COVID-19
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 71%

Outcome markers in COPD patients with COVID-19 MDPIOpenAccess COPD COVID19 SARSCoV2 outcome markers

By Dr. Liji Thomas, MDAug 8 2023Reviewed by Benedette Cuffari, M.Sc. Conflicting results have been reported on the outcome of coronavirus disease 2019 in patients with pre-existing chronic obstructive pulmonary disease . A recent prospective cohort study published in Diagnostics reports assessed patients with both conditions to try and predict the mortality risk.

Some of the factors that predict high mortality due to COVID-19 include advancing age, pre-existing conditions such as cardiovascular disease, diabetes, hypertension, COPD, cancer, chronic liver or kidney disease, poor mental health, and neurological conditions. Obesity, pregnancy, immunosuppression, and smoking have also been identified as risk factors for severe COVID-19.

Most patients were males, older than 65 years, and diagnosed with cardiovascular disease. About 25% of the study cohort required non-invasive ventilation, with 30% of these individuals eventually requiring mechanical ventilation. Of these 13 patients, nine died during the study period. Patients with a non-invasive ventilation score of -4.5 or less were at a greater risk for non-invasive ventilation in 85% of cases. This score was based on the value obtained from the polymerase chain reaction test for detecting SARS-CoV-2, the number of lung lobes affected, and presence of diabetes.

The invasive ventilation score appeared to have the greatest prediction accuracy among all three scores.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NewsMedical /  🏆 19. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Exploring the safety of COVID-19 mRNA vaccines in the elderlyExploring the safety of COVID-19 mRNA vaccines in the elderlyExploring the safety of COVID-19 mRNA vaccines in the elderly JAMANetworkOpen COVID19 covid SARSCoV2 mRNA elderly olderpersons research
Consulte Mais informação »

Is COVID-19 vaccination linked to psoriasis emergence or flare-ups?Is COVID-19 vaccination linked to psoriasis emergence or flare-ups?Is COVID-19 vaccination linked to psoriasis emergence or flare-ups? Biomed_MDPI COVID19 SARSCoV2 psoriasis vaccination vaccines
Consulte Mais informação »

How does the circulating proteome influence brain health?How does the circulating proteome influence brain health?How does the circulating proteome influence brain health? medrxivpreprint brainhealth brain health proteome
Consulte Mais informação »

Similarities in gene expression between post-mortem and living human brainsSimilarities in gene expression between post-mortem and living human brainsSimilarities in gene expression between post-mortem and living human brains medrxivpreprint geneexpression gene expression postmortem human brains humanbrain brainhealth
Consulte Mais informação »

Research develop a revolutionary toolkit to combat digital exclusionResearch develop a revolutionary toolkit to combat digital exclusionResearch develop a revolutionary toolkit to combat digital exclusion medrxivpreprint revolutionary toolkit digital exclusion digitalexclusion
Consulte Mais informação »

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency statusUnderstanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency statusUnderstanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status medrxivpreprint COVID COVID19 SARSCov2 evolution immunodeficiency covidevolution
Consulte Mais informação »



Render Time: 2025-03-01 04:26:04